Mission statement · Company scope
“Our mission is to build an oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients.”
In use2026 – now1 sighting
First seenMar 2026Added
Last seenMar 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Product offering (primary) · Market leadership · Impact
- Leads with
- Product
- Best for
- Climate & health
- Formula
- We make [product] for [who]
- Tone
- Plain
- Length
- 23 words · reading grade 16.4
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_5d87224523f6e8c2
- Classification confidence
- 0.67
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-03-03 · sec_sentence · 10-K · accession 0001193125-26-088172
View filing ↗0 to compareCompare